morten gjerstorff

Professor

University of Southern Denmark

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Morten Gjerstorff is a faculty member at the University of Southern Denmark, located in Denmark. His research primarily focuses on cancer biology, with recent articles exploring topics such as the role of myeloid-derived suppressor cells, cancer vaccination strategies, and intratumoral heterogeneity in various cancer types. He is actively involved in advancing therapeutic approaches to combat triple-negative breast cancer and improving understanding of immune evasion mechanisms in cancer cells.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Mads Hald Andersen

Professor, dr.techn., Director

DENMARK

View details

Morten Andersen

Roskilde University

DENMARK

View details

Henrik J. Ditzel

DENMARK

View details

Mikkel Terp

Associate Professor

University of Southern Denmark

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

morten gjerstorff

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis

Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer

Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?

Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance.

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1.

SSX addiction in melanoma propagates tumor growth and metastasis.

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.

Collaborators (5)

Annette Raskov Kodahl

Mads Hald Andersen

Morten Andersen

Henrik J. Ditzel

Mikkel Terp

Make your next move.